Nuovi criteri diagnostici e classificativi del diabete mellito

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183, 1997.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21(suppl 1): S5, 1998

Muggeo M, Verlato G, Bonora E, Bressan G, Girotto S, Corbellini M, Gemma ML, Moghetti P, Zenere M, Cacciatori V, Zoppini G, De Marco R. Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-yr all-cause mortality. Diabetologia 38: 318, 1995.

The DECODE Study Group on behalf of the European Diabetes Epidemiology Group: Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 42: 647, 1999.

World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part I: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva, 1999.

Società Italiana di Diabetologia. I nuovi criteri diagnostici del diabete mellito. Il Diabete 12: 221, 2000.

McCance DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated hemoglobin and fasting and 2-hour plasma glucose concentrations as diagnostic methods for diabetes. Br Med J 308: 1323, 1994.

Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycemia confirmed as a risk factor for mortality. Diabetologia 42: 1050, 1999.

Mooy JM, Gootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in general Caucasians population: the Hoorn Study. Diabetologia 39: 298, 1996.

Alberti KGMM. The clinical implications of impaired glucose tolerance. Diabet Med 13: 927, 1996.

Bonora E, Kiechl S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M. Impaired glucose tolerance, type 2 diabetes mellitus and carotid atherosclerosis. Prospective results from the Bruneck Study. Diabetologia 43: 156, 2000.

Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary heart disease risk and impaired glucose tolerance: the Withehall Study. Lancet 1: 1373, 1980.

Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years. Diabetes Care 22: 233, 1999.

Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese A, Riccardi G. Risk of diabetes in the new diagnostic category of impaired fasting glucose. Diabetes Care 22: 1490, 1999.

The DECODE Study Group on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and mortality comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354: 617, 1999.

Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15: 815, 1992.

UKPDS Group. UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 13: 1, 1990.

DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group: Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. Br Med J 317: 371, 1998.